XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Product revenue $ 893,548 $ 647,112 $ 2,385,701 $ 1,560,854
License revenue 0 21,429 0 64,286
Total revenue 893,548 668,541 2,385,701 1,625,140
Operating expenses        
Cost of sales 324,438 340,796 1,067,654 622,222
Research and development 279,049 1,143,676 774,526 3,308,009
Research and development - related party (Note 11) 291,963 47,998 387,960 143,994
Sales, general and administrative 4,385,145 2,165,135 13,732,226 5,416,038
Sales, general and administrative - related party (Note 11) 35,767 79,612 137,311 254,680
Amortization of finite-lived intangible assets 437,013 118,697 1,311,043 284,633
Total operating expenses 5,753,375 3,895,914 17,410,720 10,029,576
Loss from operations (4,859,827) (3,227,373) (15,025,019) (8,404,436)
Other (expense) income        
Interest (expense) (80,722) (4,074,668) (884,187) (4,428,136)
Derivative income (expense) 16,662 27,983 212,809 (50,054)
Unrealized gain on investment 0 0 230,936 0
(Loss) on investment (292,455) 0 (292,455) 0
Total other (expense) (356,515) (4,046,685) (732,897) (4,478,190)
Net loss $ (5,216,342) $ (7,274,058) $ (15,757,916) $ (12,882,626)
Weighted average number of common shares outstanding (in shares) 10,938,603 1,569,078 7,562,342 1,314,308
Basic and diluted net loss per common share (in dollars per share) $ (0.48) $ (4.64) $ (2.08) $ (9.80)